Literature DB >> 30776649

The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.

Alexandra M Wennberg1, Jennifer L Whitwell2, Nirubol Tosakulwong3, Stephen D Weigand3, Melissa E Murray4, Mary M Machulda5, Leonard Petrucelli4, Michelle M Mielke6, Clifford R Jack2, David S Knopman1, Joseph E Parisi7, Ronald C Petersen1, Dennis W Dickson7, Keith A Josephs8.   

Abstract

Many individuals live to older ages without clinical impairment. It is unknown whether brain pathologies in these individuals are associated with subtle clinical deficits. We analyzed the brains of 161 clinically normal (Clinical Dementia Rating score = 0) older individuals enrolled in the Mayo Clinic Patient Registry or Study of Aging. We assessed for the presence and burden of beta-amyloid, tau, alpha-synuclein, TDP-43, and vascular pathology. We investigated whether pathologies were associated with antemortem cognitive and motor function, depression, MRI volumetric measures, or the apolipoprotein E (APOE) ε4 allele. Eighty-six percent had at least 1 pathology, and 63% had mixed pathologies. Tau and vascular pathology were associated with poorer memory scores. Tau was also associated with poorer general cognition scores and smaller amygdala, hippocampi, and entorhinal cortex volumes. Beta-amyloid neuritic plaque burden was associated with greater depression scores. The presence of a greater number of pathologies was associated with APOE e4 carrier status and with poorer memory performance. Some dementia-related pathologies are associated with poorer performance in clinical measures and brain atrophy in the unimpaired elderly.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain volume; Clinically normal aging; Cognition; Depression; Neurodegenerative pathology; TDP-43; Vascular pathology

Mesh:

Substances:

Year:  2019        PMID: 30776649      PMCID: PMC6486870          DOI: 10.1016/j.neurobiolaging.2019.01.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  43 in total

1.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

Authors:  Kim N Green; Lauren M Billings; Benno Roozendaal; James L McGaugh; Frank M LaFerla
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.

Authors:  Hyun-Sik Yang; Lei Yu; Charles C White; Lori B Chibnik; Jasmeer P Chhatwal; Reisa A Sperling; David A Bennett; Julie A Schneider; Philip L De Jager
Journal:  Lancet Neurol       Date:  2018-08-06       Impact factor: 44.182

4.  Association Between Microinfarcts and Blood Pressure Trajectories.

Authors:  Jonathan Graff-Radford; Mekala R Raman; Alejandro A Rabinstein; Scott A Przybelski; Timothy G Lesnick; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; R Ross Reichard; Joseph E Parisi; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 5.  Alpha-synuclein and the Lewy body disorders.

Authors:  D W Dickson
Journal:  Curr Opin Neurol       Date:  2001-08       Impact factor: 5.710

Review 6.  Vascular pathologies and cognition in a population-based cohort of elderly people.

Authors:  Malee S Fernando; Paul G Ince
Journal:  J Neurol Sci       Date:  2004-11-15       Impact factor: 3.181

7.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

8.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

9.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2009-11-19       Impact factor: 17.088

10.  APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology.

Authors:  Dennis W Dickson; Michael G Heckman; Melissa E Murray; Alexandra I Soto; Ronald L Walton; Nancy N Diehl; Jay A van Gerpen; Ryan J Uitti; Zbigniew K Wszolek; Nilüfer Ertekin-Taner; David S Knopman; Ronald C Petersen; Neill R Graff-Radford; Bradley F Boeve; Guojun Bu; Tanis J Ferman; Owen A Ross
Journal:  Neurology       Date:  2018-08-24       Impact factor: 11.800

View more
  18 in total

Review 1.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

2.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

3.  TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease.

Authors:  Marina Buciuc; Jennifer L Whitwell; Bradley F Boeve; Tanis J Ferman; Jonathan Graff-Radford; Rodolfo Savica; Kejal Kantarci; Julie A Fields; David S Knopman; Ronald C Petersen; Joseph E Parisi; Melissa E Murray; Dennis W Dickson; Keith A Josephs
Journal:  J Neurol       Date:  2020-01-31       Impact factor: 4.849

4.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.

Authors:  Marina Buciuc; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Bradley F Boeve; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2020-04-15       Impact factor: 4.673

6.  The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.

Authors:  Zeran Li; Fabiana H G Farias; Umber Dube; Jorge L Del-Aguila; Kathie A Mihindukulasuriya; Maria Victoria Fernandez; Laura Ibanez; John P Budde; Fengxian Wang; Allison M Lake; Yuetiva Deming; James Perez; Chengran Yang; Jorge A Bahena; Wei Qin; Joseph L Bradley; Richard Davenport; Kristy Bergmann; John C Morris; Richard J Perrin; Bruno A Benitez; Joseph D Dougherty; Oscar Harari; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2019-08-27       Impact factor: 17.088

7.  Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.

Authors:  Keith A Josephs; Stephen D Weigand; Jennifer L Whitwell
Journal:  Neurology       Date:  2022-03-21       Impact factor: 11.800

8.  Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.

Authors:  Dorothee Schoemaker; Andreas Charidimou; Maria Clara Zanon Zotin; Nicolas Raposo; Keith A Johnson; Justin S Sanchez; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2021-02-24       Impact factor: 9.910

9.  The development and convergence of co-pathologies in Alzheimer's disease.

Authors:  John L Robinson; Hayley Richardson; Sharon X Xie; EunRan Suh; Vivianna M Van Deerlin; Brian Alfaro; Nicholas Loh; Matias Porras-Paniagua; Jeffrey J Nirschl; David Wolk; Virginia M-Y Lee; Edward B Lee; John Q Trojanowski
Journal:  Brain       Date:  2021-04-12       Impact factor: 15.255

10.  Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.

Authors:  L E M Wisse; S Ravikumar; R Ittyerah; S Lim; J Lane; M L Bedard; L Xie; S R Das; T Schuck; M Grossman; E B Lee; M D Tisdall; K Prabhakaran; J A Detre; G Mizsei; J Q Trojanowski; E Artacho-Pérula; M M de Iñiguez de Onzono Martin; M M Arroyo-Jiménez; M Muñoz Lopez; F J Molina Romero; M P Marcos Rabal; S Cebada Sánchez; J C Delgado González; C de la Rosa Prieto; M Córcoles Parada; D A Wolk; D J Irwin; R Insausti; P A Yushkevich
Journal:  Acta Neuropathol Commun       Date:  2021-07-21       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.